Browsing by Author Butzkueven, Helmut

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2013The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platformBarnett, Michael; Vucic, Steve; Butzkueven, Helmut; Jokubaitis, Vilija; Lechner-Scott, Jeanette; Liew, D; Shaw, C; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform, PLoS One, vol.8, 3, 2013,pp 1-9
2012Diffusion tensor imaging correlates of visual impairment in multiple sclerosis and chronic optic neuritisKlistorner, Alexander; Butzkueven, Helmut; Egan, Gary; Fielding, Joanne; Kilpatrick, T J; Kolbe, Scott; Marriott, Mark; Mitchell, Peter; van der Walt, Anneke; Central Clinical School: Clinical Ophthal & Eye HealthDiffusion tensor imaging correlates of visual impairment in multiple sclerosis and chronic optic neuritis, Investigative Ophthalmology and Visual Science, vol.53, 2, 2012,pp 825-832
2015The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function.Booth, David; McKay, Fiona Catherine; Parnell, Grant; Schibeci, Stephen; Shahijanian, Fernando; Stewart, Graeme; Butzkueven, Helmut; Field, Judith; Gresle, Melissa; Johnson, Laura; Kilpatrick, Trevor; Laverick, Louise; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Medicine; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResThe MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function., PloS One, vol.10, 6, 2015,pp e0127080-N/A
2015A new era in the treatment of multiple sclerosisBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, S; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Medicine; Central Clinical School: MedicineA new era in the treatment of multiple sclerosis, Medical Journal of Australia, vol.203, 3, 2015,pp 139-141
2015Parallel changes in structural and functional measures of optic nerve myelination after optic neuritisGraham, Stuart Lindsay; Klistorner, Alexander; Butzkueven, Helmut; Egan, Gary; Kilpatrick, Trevor; Kolbe, Scott; Mitchell, Peter; van der Walt, Anneke; Wang, Yejun; Yiannikas, Con; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Clinical Ophthal & Eye HealthParallel changes in structural and functional measures of optic nerve myelination after optic neuritis, PloS One, vol.10, 5, 2015,pp 1-11
2016Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisBarnett, Michael; Vucic, Steve; Burke, Therese Valerie; Butzkueven, Helmut; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Havrdova, Eva; Hodgkinson, Suzanne J; Horakova, Dana; Izquierdo, Guillermo; Mekhael, L; Spelman, Timothy; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis, European Journal of Neurology, vol.23, 4, 2016,pp 729-776
2016Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisBarnett, Michael; Vucic, Steve; Burke, Therese Valerie; Butzkueven, Helmut; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Havrdova, Eva; Hodgkinson, Suzanne J; Horakova, Dana; Izquierdo, Guillermo; Mekhael, L; Spelman, Timothy; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis, European Journal of Neurology, vol.23, 4, 2016,pp 729-776
2016Serial Diffusion Tensor Imaging of the Optic Radiations after Acute Optic NeuritisKlistorner, Alexander; Butzkueven, Helmut; Egan, Gary; Kilpatrick, Trevor; Kolbe, Scott; van der Walt, Anneke; Central Clinical School: Clinical Ophthal & Eye HealthSerial Diffusion Tensor Imaging of the Optic Radiations after Acute Optic Neuritis, Journal of Ophthalmology, vol.2016, N/A, 2016,pp 1-6
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapiesBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1835-1846
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacyBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1847-1856
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendationsBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Taylor, Bruce V.; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1857-1865